ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation

Molecular Medicine

Volumn 5, Issue 7, 1999, Pages 477-489

  Volbracht, Christiane ^a   Leist, Marcel ^a   Nicotera, Pierluigi ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; CASPASE; CASPASE INHIBITOR; COLCHICINE; DEOXYGLUCOSE; NOCODAZOLE; POTASSIUM; S NITROSOGLUTATHIONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LOSS; ENZYME INHIBITION; IMMUNOCYTOCHEMISTRY; MICROTUBULE; MOUSE; NERVE CELL DEGENERATION; NERVE INJURY; NONHUMAN; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0032810012     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403541     Document Type: Article

References (59)

1. Leist M, Nicotera P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239: 183-201.
2. Nicotera P, Leist M, Manzo L. (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20: 46-51.
3. Stroh C, Schulze-Osthoff K. (1998) Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ. 5: 997-1000.
4. Wyllie AH, Kerr JF, Currie AR. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
5. Krahling S, Callahan MK, Williamson P, Schlegel RA. (1999) Exposure of phosphatidyl-serine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 6: 183-189.
6. Ren Y, Savill J. (1998) Apoptosis: the importance of being eaten. Cell Death Differ. 5: 563-568.
7. Savill J, Fadok V, Henson P, Haslett C. (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14: 131-136.
8. Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H. (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptotis. J. Neuropathol. Exp. Neurol. 57: 456-464.
9. Barinaga M. (1998) Is apoptosis key in Alzheimer's disease? Science 281: 1303-1304.
10. Hsia AY, Masliah E, McConlogue L, et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 96: 3228-3233.
11. Braak H, Braak E. (1998) Cortical destruction and cell death in Alzheimer's disease. In: Koliatsos VE, Ratan RR (eds). Cell Death and Diseases of the Nervous System. Humana Press, Totowa, NJ, pp 497-510.
12. Li P, Nijhawan D, Budihardjo I, et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.
13. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
14. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. (1997) Intracellular ATP concentration: a switch deciding between apoptosis and necrosis. J. Exp. Med. 185: 1481-1486.
15. Eguchi Y, Shimizu S, Tsujimoto Y. (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57: 1835-1840.
16. Ankarcrona M, Dypbukt JM, Bonfoco E, et al. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
17. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV. (1994) Complex I inhibitors induce dose-dependent apoptosis in PC 12 cells: relevance to Parkinson's disease. J. Neurochem. 63: 1987-1990.
18. Leist M, Volbracht C, Kühnle S, Fava E, Ferrando-May E, Nicotera P. (1997) Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3: 750-764.
19. Ceccatelli S, Ahlbom E, Diana A, Zhivotovsky B. (1997) Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine. Neuroreport 8: 3779-3783.
20. Bonfoco E, Ceccatelli S, Manzo I., Nicotera P. (1995) Colchicine induces apoptosis in cerebellar granule cells. Exp. Cell Res. 218: 189-200.
21. Schousboe A, Meier E, Drejer J, Hertz L. (1989) Preparation of primary cultures of mouse (rat) cerebellar granule cells., In: Shahar A, de Vellis J, Vernadakis A, Haber B (eds). A Dissection and Tissue Culture Manual of the Nervous System. Alan R. Liss, New York, pp 203-206.
22. +) induces autocrine excitotoxicity, protease activation and neuronal apoptosis. Mol Pharmacol. 54: 789-801.
23. Leist M, Fava E, Montecucco C, Nicotera P. (1997) Peroxynitrite and NO-donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9: 1488-1498.
24. Leist M, Kühnle S, Single B, Nicotera P. (1998) Differentiation between apoptotic and necrotic cell death by means of the BM cell death detection ELISA or annexin V staining. Biochemica 2: 25-28.
25. Leist M, Gantner F, Bohlinger I, German PG, Tiegs G, Wendel A. (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J. Immunol. 153: 1778-1787.
26. Thornberry NA. (1994) Interleukin-1 beta converting enzyme. Methods Enzymol. 244: 615-631.
27. Leist M, Single B, Künstle G, Volbracht C, Hentze H, Nicotera P. (1997) Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 233: 518-522.
28. Tietze F. (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal. Biochem. 27: 502-522.
29. Jänicke RU, Ng P, Sprengart ML, Porter AG. (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273: 15540-15545.
30. Leist M, Single B, Naumann H, et al. (1999) Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun. 258: 215-221.
31. Schulz JB, Weller M, Klockgether T. (1996) Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J. Neurosci. 16: 4696-4706.
32. 2+ homeostasis. J. Neurochem. 66: 403-411.
33. Beal MF. (1996) Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6: 661-666.
34. Mattson MP. (1997) Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 20: 373-375.
35. Blandini F, Higgins DSJ, Greene JG, Greenamyre JT. (1997) Glutamate and mitochondrial defects in neurodegeneration. In: Beal MF, Howell N, Bodis-Wollner I (eds). Mitochondria and Free Radicals in Neurodegenerative Diseases. Wiley-Liss, New York, pp 145-158.
36. Bolanos JP, Almeida A, Stewart V, et al. (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68: 2227-2240.
37. Wallace DC, Lott MT, Brown MD. (1997) Mitochondrial defects in neurodegenerative diseases and aging. In: Beal MF, Howell N, Bodis-Wollner I (eds). Mitochondria and Free Radicals in Neurodegenerative Diseases. Wiley-Liss, New York, pp 283-307.
38. Wallace DC. (1999) Mitochondrial diseases in man and mouse. Science 283: 1482-1488.
39. Leist M, Single B, Naumann H, et al. (1999) Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp. Cell Res. 249: 396-403.
40. Clementi E, Brown GC, Feelisch M, Moncada S. (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondria complex I and protective action of glutathione. Proc. Natl. Acad. Sci. U.S.A. 95: 7631-7636.
41. Clecter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative disease. FEBS Lett. 345: 50-54.
42. Schweizer M, Richter C. (1994) Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem. Biophys. Res. Commun. 204: 169-175.
43. Henneberry RC, (1997) Excitotoxicity as a consequence of impairment of energy metabolism: the energy-linked excitotoxic hypothesis. In: Beal MF, Howell N, Bodis-Wollner I (eds). Mitochondria and Free Radicals in Neurogenerative Diseases. Wiley-Liss, New York, pp 111-143.
44. Whitfield JF, Brohec H, (1966) Prevention of nuclear damage in irradiated rat thymocytes by post-irradiation oxygen deprivation. Nature 211: 775-776.
45. Leist M, Gantner F, Künstle G, Wendel A. (1998) Cytokine-mediated hepatic apoptosis. Rev. Physiol. Biochem. Pharmacol. 133: 109-155.
46. Tipton KF, Singer TP. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61: 1191-1206.
47. Nicklas WJ, Vyas I, Heikkila RE. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36: 2503-2508.
48. Dimmeler S, Zeiher AM. (1997) Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275-281.
49. Tenneti T., D'Emilia DM, Lipton SA. (1997) Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. 236: 139-142.
50. Kharlamov E, Cagnoli CM, Atabay C, Ikonomovic S, Grayson DR, Manev H. (1995) Opposite effect of protein synthesis inhibitors on potassium deficiency-induced apoptotic cell death in immature and mature neuronal cultures. J. Neurochem. 65: 1395-1398.
51. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM. (1988) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106: 829-844.
52. Ceccatelli S, Villar MJ, Goldstein M, Hökfelt T. (1989) Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc. Natl. Acad. Sci. U.S.A. 86: 9569-9573.
53. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hökfelt T. (1991) Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc. Natl. Acad. Sci. U.S.A. 88: 10352-10356.
54. Martin SJ, Lennon SV, Bonham AM, Cotter TG. (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145: 1859-1867.
55. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell Biol. 18: 3509-3517.
56. Evtodienko YV, Teplova VV, Sidash SS, Ichas F, Mazat JP. (1996) Microtubule-active drugs suppress the closure of the permeability transition pore in tumor mitochondria. FEBS Lett. 393: 86-88.
57. Basu A, Haldar S. (1998) Microtubule-damaging drugs triggered Bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of Bcl2 protein. Int. J. Oncol. 13: 659-664.
58. Hirsch T, Marchetti P, Susin SA, et al. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15: 1573-1581.
59. Green D, Kroemer G. (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8: 267-271.